Rajiv de Silva, Chief Operating Officer at VALEANT PHARMACEUTICALS INTERNATIONAL (VRX), bought 11,595 shares at $17.28 ($200K) on 2009-02-27, disclosed to the SEC on 2009-03-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ENDP | BUY | 2015-11-12 | $500K | — | Filing → |
| VRX | SELL | 2012-11-09 | $4.1M | — | Filing → |
| VRX | SELL | 2012-11-08 | $12.0M | — | Filing → |